Lenvatinib plus pembrolizumab has improved survival rates for patients with intermediate-stage hepatocellular cancer, ...

张辉：冠心病疗法的又一选择——揭秘“不开刀的心脏搭桥手术” ...

(esmo), a leading global full-service systems integrator, developer, and supplier of innovative and advanced automation ...

Patients with Lung Cancer who had Exhausted All Other Treatment Options Achieved Prolonged Progression Free Survival Following Treatment with NUC-3373 plus Docetaxel EDINBURGH, United Kingdom, (GLOBE ...

河南工业大学尚宇红：呵护心灵，共筑心理健康！

Most common AE is myelosuppression, GI side effect, and transient hypertension. There were no treatment-related deaths. Results are consistent with the data reported on the first 19 patients in Study ...

Incorporating perioperative durvalumab into treatment with neoadjuvant chemotherapy and radical cystectomy prolongs ...

Patients with dMMR colon cancer in a trial for two neoadjuvant cycles of nivolumab/ipilimumab or nivolumab/relatlimab, had ...

TG4050: Promising Phase I data to be presented at SITC 2024 providing clinical proof of principle in adjuvant head and neck cancer setting Financial visibility confirmed into Q4 2025 Strasbourg, ...